Ischemic heart disease is any condition where the heart muscle doesn’t get enough blood flow to meet its needs. That includes obvious cases like heart attacks and chest pain from blocked arteries, but it also covers situations where the arteries look clear on imaging yet the heart still isn’t getting adequate supply. The formal medical classification groups these conditions into six categories: angina, acute heart attack, subsequent heart attacks, complications following a heart attack, other acute ischemic events, and chronic ischemic heart disease.
The Core Problem: Reduced Blood Flow
The defining feature of all ischemic heart disease is a mismatch between how much oxygen the heart muscle demands and how much it actually receives. This can happen through several mechanisms, not just one. The most well-known is a buildup of fatty plaques inside the coronary arteries that physically narrows the channel for blood flow. But it can also result from temporary spasms that squeeze an artery shut, or from dysfunction in the tiny blood vessels within the heart muscle itself.
The degree of narrowing matters. When imaging shows less than 50% narrowing of an artery’s diameter, ischemia is unlikely. When narrowing reaches 90% or more, roughly three out of four patients will have detectable ischemia even without symptoms. The range between 50% and 89% is where further testing becomes essential to determine whether the blockage is actually starving the heart of blood or just sitting there without causing harm.
Conditions That Fall Under the Diagnosis
Ischemic heart disease is not a single condition. It’s an umbrella term covering a wide spectrum.
Angina
Angina is chest pain or pressure caused by reduced blood flow to the heart. Stable angina follows a predictable pattern that has been consistent for at least two months: it shows up during exertion or stress, lasts a few minutes, and goes away with rest or medication. Unstable angina breaks that pattern. It may come on at rest, feel stronger or last longer than usual, and not respond to rest or medication. Unstable angina is a medical emergency because it signals a blockage that could progress to a full heart attack.
Vasospastic angina is a third type caused by a temporary, intense contraction of a coronary artery rather than a fixed blockage. It typically strikes at rest, often between midnight and early morning, and responds well to a specific class of blood pressure medications but not to beta blockers.
Heart Attack
A heart attack (myocardial infarction) occurs when blood flow to part of the heart is completely or nearly completely cut off long enough to damage or kill heart muscle cells. This is the acute, most dangerous form of ischemic heart disease. It qualifies as ischemic heart disease whether it’s a first event or a subsequent one, and whether the blockage shows a specific pattern on an EKG (called ST elevation) or not.
Chronic Ischemic Heart Disease
This is the long-term form. It includes people living with known coronary artery disease, those who have had a previous heart attack or procedure to open blocked arteries and have since stabilized, and those with heart failure caused by inadequate blood supply over time. You can carry this diagnosis for years or decades while managing it with lifestyle changes and medication.
Ischemia Without Major Blockages
One of the most important developments in cardiology over the past decade is recognizing that ischemic heart disease doesn’t require a severely blocked artery. A condition called INOCA (ischemia with non-obstructive coronary arteries) qualifies when three criteria are met: you have chronic chest symptoms, there is objective evidence of ischemia on testing, and no artery is narrowed by 50% or more.
INOCA is typically caused by problems in the smallest blood vessels of the heart (microvascular dysfunction) or by coronary artery spasm. Microvascular dysfunction is diagnosed when specialized blood flow measurements fall below specific thresholds during catheterization. Coronary spasm is confirmed when a provocative test triggers more than 90% constriction of an artery along with chest pain and EKG changes. Both count as ischemic heart disease even though a standard angiogram may look normal.
Silent Ischemia: No Symptoms at All
Ischemic heart disease can also be diagnosed in people who never experience chest pain, shortness of breath, or any other symptom. Silent myocardial ischemia is defined as objective evidence of reduced blood flow to the heart without any accompanying discomfort. It’s often discovered incidentally during a routine stress test or ambulatory heart monitor.
The evidence can come from ST segment changes on an EKG during exercise, or from reversible defects on a nuclear imaging scan, meaning areas of the heart that don’t get enough blood during stress but recover at rest. Silent ischemia carries the same long-term risks as symptomatic ischemia, which is why screening matters in people with risk factors like diabetes, high blood pressure, or a strong family history.
How Testing Confirms the Diagnosis
Several tests can establish that ischemia is present, and each looks at the problem from a different angle.
An exercise stress test with EKG monitoring is often the first step. The key finding is ST segment depression on the EKG tracing. Horizontal or downsloping depression of 1 mm or more during exercise is the standard threshold for a positive result. Even depression just under 1 mm can be considered abnormal if it occurs at low exercise levels, because a person who develops changes with minimal exertion is more likely to have significant disease.
Stress echocardiography adds ultrasound imaging before and after exercise or medication-induced stress. The test is positive when areas of the heart wall that moved normally at rest develop new or worsening motion abnormalities under stress. This directly shows which segments of the heart aren’t getting enough blood.
Nuclear perfusion imaging uses a small amount of radioactive tracer to map blood flow through the heart muscle. Areas that light up at rest but go dark under stress indicate ischemia. Areas that stay dark in both conditions suggest prior damage, like scar tissue from a past heart attack.
Coronary CT angiography provides detailed images of the arteries themselves, showing the location and severity of any narrowing. It’s particularly useful for ruling out significant disease: less than 50% narrowing on CT strongly predicts the absence of ischemia.
Fractional flow reserve (FFR) is the most precise measurement, performed during cardiac catheterization. A thin wire measures the pressure difference across a blockage to determine whether it’s actually restricting flow. An FFR value below 0.75 reliably identifies a blockage that is producing ischemia, with 100% specificity in studies. Values above 0.80 rule out significant ischemia with over 95% accuracy. The range between 0.75 and 0.80 is a gray zone where clinical judgment and additional information guide the decision. The widely accepted cutoff used in major clinical trials and endorsed by professional societies is 0.80 or below.
What Ties These Conditions Together
Whether it’s a massive heart attack, stable chest pain that comes on during a morning jog, or an incidental finding on a stress test with no symptoms at all, the qualifying feature is the same: the heart muscle is not receiving the blood flow it needs. The cause can be a fixed blockage, a temporary spasm, or dysfunction in vessels too small to see on a standard angiogram. The 2023 guidelines from the American Heart Association and American College of Cardiology explicitly include all of these under the umbrella of chronic coronary disease, recognizing it as a heterogeneous group of conditions rather than a single entity defined solely by clogged arteries.
This broader definition matters because it determines who receives treatment and monitoring. A person with clear arteries but confirmed microvascular dysfunction qualifies for the same diagnostic label and ongoing care as someone with a 90% blockage in a major artery. Both have ischemic heart disease. Both face elevated cardiovascular risk. And both benefit from therapies tailored to their specific mechanism of reduced blood flow.